FI104149B1 - Förfarande för framställning av fördröjt frigörande blandningar - Google Patents

Förfarande för framställning av fördröjt frigörande blandningar

Info

Publication number
FI104149B1
FI104149B1 FI913646A FI913646A FI104149B1 FI 104149 B1 FI104149 B1 FI 104149B1 FI 913646 A FI913646 A FI 913646A FI 913646 A FI913646 A FI 913646A FI 104149 B1 FI104149 B1 FI 104149B1
Authority
FI
Finland
Prior art keywords
sustained release
preparing sustained
release mixtures
mixtures
preparing
Prior art date
Application number
FI913646A
Other languages
English (en)
Finnish (fi)
Other versions
FI913646A0 (fi
FI104149B (sv
FI913646L (fi
Inventor
Jean-Marc Ruiz
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of FI913646A0 publication Critical patent/FI913646A0/fi
Publication of FI913646L publication Critical patent/FI913646L/fi
Application granted granted Critical
Publication of FI104149B1 publication Critical patent/FI104149B1/sv
Publication of FI104149B publication Critical patent/FI104149B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
FI913646A 1990-08-01 1991-07-31 Förfarande för framställning av fördröjt frigörande blandningar FI104149B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions

Publications (4)

Publication Number Publication Date
FI913646A0 FI913646A0 (fi) 1991-07-31
FI913646L FI913646L (fi) 1992-02-02
FI104149B1 true FI104149B1 (sv) 1999-11-30
FI104149B FI104149B (sv) 1999-11-30

Family

ID=10679993

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913646A FI104149B (sv) 1990-08-01 1991-07-31 Förfarande för framställning av fördröjt frigörande blandningar

Country Status (30)

Country Link
US (1) US5213812A (sv)
JP (1) JP2818704B2 (sv)
KR (1) KR920003962A (sv)
AT (1) AT396425B (sv)
AU (2) AU649696B2 (sv)
BE (1) BE1004772A3 (sv)
CA (1) CA2048270C (sv)
CH (1) CH682715A5 (sv)
DE (1) DE4125542A1 (sv)
DK (1) DK175756B1 (sv)
ES (1) ES2046083B1 (sv)
FI (1) FI104149B (sv)
FR (1) FR2665360B1 (sv)
GB (1) GB9016885D0 (sv)
GR (1) GR1001512B (sv)
HK (1) HK33294A (sv)
IE (1) IE65124B1 (sv)
IN (1) IN178446B (sv)
IT (1) IT1251788B (sv)
LU (1) LU87982A1 (sv)
MA (1) MA22245A1 (sv)
MY (1) MY107500A (sv)
NL (1) NL194637C (sv)
NO (1) NO300158B1 (sv)
NZ (1) NZ238981A (sv)
OA (1) OA09387A (sv)
PT (1) PT98497B (sv)
SE (1) SE505734C2 (sv)
TN (1) TNSN91067A1 (sv)
ZA (1) ZA915565B (sv)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
US5569467A (en) * 1993-05-15 1996-10-29 Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) Process for the preparation of microballs and microballs thus obtained
DE69529054T2 (de) * 1994-02-28 2003-08-21 Nanopharm Ag System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
CA2267930A1 (en) * 1996-10-09 1998-04-16 Nobuyuki Takechi A method for producing a microparticle
AR012448A1 (es) * 1997-04-18 2000-10-18 Ipsen Pharma Biotech Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
EP1079967A4 (en) 1998-04-13 2003-07-23 Luminex Corp LIQUID MARKING USING FLUORESCENT MICROPARTICLES
DK1140026T3 (da) * 1998-12-16 2006-01-02 Aventis Pharma Inc Serotoninreceptorantagonist indkapslet i biologisk nedbrydelig polymer og fremgangsmåde til fremstilling af samme
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
EP1335661B1 (en) 2000-10-27 2009-05-06 Baxter Healthcare S.A. Production of microspheres
ATE395042T1 (de) * 2001-08-16 2008-05-15 Baxter Int Darreichungsformen welche mikropartikel und treibgas enthalten
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
US20040166077A1 (en) * 2002-12-04 2004-08-26 L'oreal Process for treating keratin materials with aromatic active principles
FR2848113B1 (fr) * 2002-12-04 2005-02-25 Oreal Stabilisation de principes actifs aromatiques par des polymeres aromatiques
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
RU2426590C2 (ru) * 2003-07-18 2011-08-20 Бакстер Интернэшнл Инк. Способы изготовления, применение и композиции небольших сферических частиц, приготовленных регулируемым фазовым разделением
US20050048127A1 (en) * 2003-07-22 2005-03-03 Larry Brown Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
US20060135277A1 (en) * 2003-09-10 2006-06-22 Marnocha Bendict F Golf club and practice arrangement
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
DK2072040T3 (da) 2004-05-12 2013-07-29 Baxter Healthcare Sa Terapeutisk anvendelse af nukleinsyremikrokugler
WO2005112885A2 (en) * 2004-05-12 2005-12-01 Baxter International Inc. Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
US8333995B2 (en) * 2004-05-12 2012-12-18 Baxter International, Inc. Protein microspheres having injectable properties at high concentrations
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
JP2008506700A (ja) * 2004-07-13 2008-03-06 アルテアーナノ，インコーポレーテッド 薬物の制御された放出のためのセラミック構造体
JP2008506699A (ja) * 2004-07-13 2008-03-06 アルテアーナノ，インコーポレーテッド 薬物転用防止用セラミック構造体
US20070243234A1 (en) * 2004-10-29 2007-10-18 Peter Gabriele Microscopic Tagging System for Security Identification
AU2006241145B2 (en) * 2005-04-27 2011-04-28 Baxter Healthcare S. A. Surface-modified microparticles and methods of forming and using the same
JP2009505824A (ja) * 2005-08-23 2009-02-12 アルテアナノ インコーポレイテッド 高度な光触媒のリンドープアナターゼＴｉＯ２組成物及びその製造方法
US20080008843A1 (en) * 2006-03-02 2008-01-10 Fred Ratel Method for Production of Metal Oxide Coatings
WO2007103812A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Method for low temperature production of nano-structured iron oxide coatings
WO2007103820A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Nanostructured indium-doped iron oxide
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
JP5118139B2 (ja) 2006-08-04 2013-01-16 バクスター・インターナショナル・インコーポレイテッド 新規発症自己免疫性糖尿病を予防および／または逆転させるためのマイクロスフィアに基づく組成物
EP2068845A2 (en) * 2006-10-06 2009-06-17 Baxter International Inc. Microencapsules containing surface-modified microparticles and methods of forming and using the same
JP2010505883A (ja) 2006-10-12 2010-02-25 ザ ユニバーシティー オブ クイーンズランド 免疫応答を調節するための組成物および方法
US20090169628A1 (en) 2006-10-17 2009-07-02 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials
US20080254258A1 (en) * 2007-04-12 2008-10-16 Altairnano, Inc. Teflon® replacements and related production methods
CN101686939B (zh) * 2007-04-17 2013-03-27 巴克斯特国际公司 用于肺部投送的核酸微粒
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
AU2009237577B2 (en) 2008-04-18 2014-06-05 Baxter Healthcare Sa Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
WO2010037021A2 (en) * 2008-09-29 2010-04-01 Armark Authentication Technologies, Llc Spinneret and method of spinning fiber
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
US20100291384A1 (en) * 2009-05-15 2010-11-18 Armark Authentication Technologies, Llc Fiber having non-uniform composition and method for making same
CA2762653A1 (en) * 2009-05-27 2010-12-02 Selecta Biosciences, Inc. Immunomodulatory agent-polymeric compounds
WO2011038053A1 (en) * 2009-09-25 2011-03-31 Armark Authentication Technologies, Llc Tissue fiber scaffold and method for making
AU2011258165B2 (en) 2010-05-26 2016-11-17 Selecta Biosciences, Inc. Dose selection of adjuvanted synthetic nanocarriers
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique
BR112013010926A2 (pt) 2010-11-01 2016-08-23 Univ Technology Sidney agentes imunomoduladores e seus usos
JP2014521687A (ja) 2011-07-29 2014-08-28 セレクタ バイオサイエンシーズ インコーポレーテッド 体液性および細胞傷害性ｔリンパ球（ｃｔｌ）免疫応答を生成する合成ナノキャリア
EP3149049B1 (en) 2014-05-27 2022-10-26 The University Of Queensland Il-22 for use in treating metabolic disorders
FR3067226B1 (fr) * 2017-06-13 2021-10-08 Rossignol Lange Element de chaussure de ski

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567650A (en) * 1969-02-14 1971-03-02 Ncr Co Method of making microscopic capsules
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IN167096B (sv) * 1985-04-04 1990-09-01 Akzo Nv
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
AU4369589A (en) * 1988-10-27 1990-05-03 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device

Also Published As

Publication number Publication date
MA22245A1 (fr) 1992-04-01
FR2665360B1 (fr) 1995-02-10
NL194637B (nl) 2002-06-03
NO912986L (no) 1992-02-03
JPH05178740A (ja) 1993-07-20
PT98497B (pt) 1997-10-31
MY107500A (en) 1995-12-30
TNSN91067A1 (fr) 1992-10-25
NL9101306A (nl) 1992-03-02
LU87982A1 (fr) 1992-04-15
ITMI911953A1 (it) 1993-01-15
GR910100330A (en) 1992-08-31
BE1004772A3 (fr) 1993-01-26
AU666808B2 (en) 1996-02-22
US5213812A (en) 1993-05-25
FI913646A0 (fi) 1991-07-31
ES2046083B1 (es) 1994-08-01
IE912700A1 (en) 1992-02-12
CA2048270A1 (en) 1992-02-02
DK175756B1 (da) 2005-02-14
HK33294A (en) 1994-04-22
NZ238981A (en) 1992-11-25
IT1251788B (it) 1995-05-26
IE65124B1 (en) 1995-10-04
ES2046083A1 (es) 1994-01-16
KR920003962A (ko) 1992-03-27
ZA915565B (en) 1992-04-29
FI104149B (sv) 1999-11-30
AU649696B2 (en) 1994-06-02
ITMI911953A0 (it) 1991-07-15
DK141891A (da) 1992-02-02
AU5939394A (en) 1994-06-02
SE9102249D0 (sv) 1991-07-26
JP2818704B2 (ja) 1998-10-30
AU8146691A (en) 1992-02-06
FI913646L (fi) 1992-02-02
IN178446B (sv) 1997-05-03
DK141891D0 (da) 1991-07-31
SE505734C2 (sv) 1997-10-06
SE9102249L (sv) 1992-02-02
NL194637C (nl) 2002-10-04
GR1001512B (el) 1994-02-28
NO912986D0 (no) 1991-07-31
CH682715A5 (fr) 1993-11-15
CA2048270C (en) 1997-02-25
PT98497A (pt) 1992-06-30
FR2665360A1 (fr) 1992-02-07
DE4125542A1 (de) 1992-02-06
ATA152591A (de) 1993-01-15
OA09387A (fr) 1992-09-15
GB9016885D0 (en) 1990-09-12
AT396425B (de) 1993-09-27
NO300158B1 (no) 1997-04-21

Similar Documents

Publication Publication Date Title
FI104149B1 (sv) Förfarande för framställning av fördröjt frigörande blandningar
FI101676B1 (sv) Förbättrat förfarande för framställning av en stabil mikrosfärkomposition
FI932850A7 (fi) Process foer kontinuerlig framstaellning av hoegmodulsprodukter av hoegmolekylviktsplaster
FI925531L (fi) Process foer framstaellning av poroesa cellulosamatriser
DK0454386T3 (da) Fremgangsmåde til fremstilling af saccharose-6-ester
FI915573A7 (sv) Förfarande för framställning av cellulosaformkroppar
DE69026613D1 (de) Transalkylierungsverfahren
DE69115992D1 (de) Schlickergussverfahren
FI925988A7 (sv) Förfarande för framställning av B-laktamer
FI940769A7 (sv) Förfarande för framställning av 2-aminotiazolderivat
FI940280L (sv) Förfarande för framställning av demetylepydofyllotoxin
FI924674L (fi) En foerbaettrad process foer framstaellning av substituerade indolanderivat
FI891677L (sv) Förfarande för framställning av 4-demetoxidaunomycinon
FI912868A7 (sv) Förfarande för framställning av farmaceutiska föreningar
FI921319A7 (sv) Förfarande för framställning av kinolinderivat
FI925260L (sv) Förfarande för framställning av terapeutiskt användbara 6-amino-substituerade oktahydro-1,7,8-indolizintriolderivat
FI98459B (sv) Förfarande för framställning av terapeutiskt användbara 5-etano-2,3,4,5-1H-2-bentsazsepin
NO914056D0 (no) Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat
FI925806A7 (sv) Förfarande för framställning av metylhydroxialkylcellulosaetrar
FI912626A7 (sv) Förfarande för framställning av B-hydroxi-a-aminosyror
MX9101668A (es) Proceso para preparar derivados de 8-cloroquinolona
FI960332A0 (sv) Förfarande för framställning av substituerade 4,6-diamino-5-cyano-pyrimidiner
DK0465373T3 (da) Fremgangsmåde til fremstilling af kappa-carragenaner
FI900296A7 (sv) Förfarande för framställning av pre-insulin
FI910366L (sv) Förfarande för framställning av deoximulundokandin